GlassScriptPhysician profile
Tedman L Tan
NPI 1568857365
$2,829.73
in general payments reported to CMS, 2019-2025
25 companies · $82.42 in 2025
The $82.42 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $213 · 2021: $903 · 2022: $595 · 2023: $335 · 2024: $327 · 2025: $82.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $474.22 | 2021-2024 | |
| Smith+Nephew, INC. | $337.48 | 2019-2024 | Collagenase Santyl, Regranex |
| Stryker Corporation | $311.01 | 2019-2021 | |
| Misonix INC | $271.85 | 2020-2021 | |
| Kerecis Limited | $261.52 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $178.41 | 2019-2021 | |
| Next Science LLC | $148.76 | 2023 | Blastx, Xperience, Surgx |
| Organogenesis INC. | $146.88 | 2021-2025 | Via Matrix, Matrix |
| Abbott Laboratories | $126.81 | 2022 | |
| Zimmer Biomet Holdings, INC. | $124.03 | 2022 | |
| Kci USA, INC. | $88.25 | 2019-2022 | |
| Depuy Synthes Sales INC. | $48.57 | 2019-2023 | N/A, Minibunion, Motoband |
| Paratek Pharmaceuticals, INC. | $47.85 | 2021-2025 | Nuzyra |
| Nevro Corp. | $46.70 | 2022-2024 | Senza |
| Orthofix Medical, INC. | $37.21 | 2024 | Physio-Stim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $35.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.68 | 2023 | Seglentis |
| Solventum Corporation | $20.27 | 2024 | Activ.A.C. |
| Acera Surgical, INC. | $17.08 | 2022 | |
| Koya Medical, INC. | $16.75 | 2025 | Koya Medical, Dayspring |
| Medtronic, INC. | $13.28 | 2023 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $13.07 | 2019 | |
| Grt US Holding, INC. | $12.71 | 2021 | |
| Zyla Life Sciences, INC. | $11.31 | 2020 | |
| Cashflow Solutions, LLC | $11.08 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tedman Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.